PKM and neoplasm: Epigenetically, PRL-3 promotes primary tumor proliferation and metastatic capacity by upregulating PKM2 and glycolytic enzymes such as Glut1, HK2, and LDHA, collectively enhancing glucose uptake and lactate production (71).